Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807512-44-2
1964503-39-6 | Carboxy-peg4-phosphonic acid ethyl ester | AA019E4T | MFCD30182034
2100306-68-9 | Benzyloxy carbonyl-peg3-nhs ester | AA019E9A | MFCD30723240
2144777-90-0 | Propyl-peg4-nhs | AA019EDW | MFCD31561128
1206824-76-1 | tert-Butyl (2-carbamoyl-1H-pyrrol-1-yl)carbamate | AA019EHN | MFCD24471141
1935392-13-4 | 1-(tert-Butoxycarbonyl)-4-hydroxy-3-methylpyrrolidine-3-carboxylic acid | AA019EKK | MFCD28965051
1571065-36-5 | 2-(2,6-Dichloro-3-fluorophenyl)ethanol | AA019ENZ | MFCD29917028
906649-94-3 | 1,3-Dibromo-5-fluoro-2-methylbenzene | AA019EQX | MFCD25968694
313981-48-5 | N-(2-Chloro-5-(trifluoromethyl)phenyl)-4-methoxybenzenesulfonamide | AA019ETX | MFCD00784315
1396779-52-4 | ethyl 1-isopropyl-6-(((trifluoromethyl)sulfonyl)oxy)-1H-pyrazolo[3,4-b]pyridine-4-carboxylate | AA019EXG | MFCD31692226
98717-15-8 | 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-,monohydrochloride, (2S)- | AA019FPT | MFCD02102164